These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 6538503)
81. Management of non-small-cell cancer. Soukop M Recent Results Cancer Res; 1984; 92():79-88. PubMed ID: 6204364 [No Abstract] [Full Text] [Related]
82. Bortezomib, cyclophosphamide, and dexamethasone: highly effective for rapid reversal of myeloma-associated hyperammonemic encephalopathy. Howman R; Thakerer A; Pitman M; Ding N; Thompson PA; Khot A; Harrison SJ Leuk Lymphoma; 2010 Dec; 51(12):2299-302. PubMed ID: 20929329 [No Abstract] [Full Text] [Related]
83. A comparison of vincristine and doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C-VAMP) as induction treatment followed by autografting in previously untreated myeloma. Raje N; Powles R; Kulkarni S; Milan S; Middleton G; Singhal S; Mehta J; Millar B; Viner C; Raymond J; Treleaven J; Cunningham D; Gore M Br J Haematol; 1997 Apr; 97(1):153-60. PubMed ID: 9136958 [TBL] [Abstract][Full Text] [Related]
84. Outcomes of patients with multiple myeloma and renal impairment treated with bortezomib, cyclophosphamide, and dexamethasone without plasma exchange. Costa LJ; Abbas J; Ortiz-Cruz KL; Kang Y; Stuart RK Eur J Haematol; 2012 Nov; 89(5):432-4. PubMed ID: 22971164 [No Abstract] [Full Text] [Related]
85. The current status and future prospects of treatment for multiple myeloma. Durie BG; Salmon SE Clin Haematol; 1982 Feb; 11(1):181-210. PubMed ID: 6176381 [No Abstract] [Full Text] [Related]